monARCbio

The monARC Bionetworks multi-discipline team of drug development and digital technology experts have created a comprehensive end-to-end clinical research platform that enables earlier and broader collaboration between patients, providers, and researchers to exponentially accelerate drug development. monARC Bionetworks integrated research platform and approach exponentially accelerates clinical trial cycle times by transforming a highly sequential and siloed drug development model into an integrated and collaborative model between patients, providers, and researchers without sacrificing the principles of evidence based medicine, monARC Bionetworks converges clinical practice with clinical care to accelerate research and adoption of medical innovations and new quality standards. The monARC Bionetworks approach creates a new pathway for adaptive and pragmatic trials that are necessary to realize the full promise of Precision Medicine that will personalize healthcare and improve outcomes.